379 related articles for article (PubMed ID: 21225432)
1. Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas.
Vogt M; Munding J; Grüner M; Liffers ST; Verdoodt B; Hauk J; Steinstraesser L; Tannapfel A; Hermeking H
Virchows Arch; 2011 Mar; 458(3):313-22. PubMed ID: 21225432
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer.
Lodygin D; Tarasov V; Epanchintsev A; Berking C; Knyazeva T; Körner H; Knyazev P; Diebold J; Hermeking H
Cell Cycle; 2008 Aug; 7(16):2591-600. PubMed ID: 18719384
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of potential tumor suppressor miR-34b/c is correlated with late clinical stage in patients with soft tissue sarcomas.
Xie Y; Zong P; Wang W; Liu D; Li B; Wang Y; Hu J; Ren Y; Qi Y; Cui X; Chen Y; Liu C; Li F
Exp Mol Pathol; 2015 Jun; 98(3):446-54. PubMed ID: 25773680
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic inactivation of DAPK1, p14ARF, mir-34a and -34b/c in acute promyelocytic leukaemia.
Ng HY; Wan TS; So CC; Chim CS
J Clin Pathol; 2014 Jul; 67(7):626-31. PubMed ID: 24811488
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T
Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9-mediated inactivation of miR-34a and miR-34b/c in HCT116 colorectal cancer cells: comprehensive characterization after exposure to 5-FU reveals EMT and autophagy as key processes regulated by miR-34.
Huang Z; Kaller M; Hermeking H
Cell Death Differ; 2023 Aug; 30(8):2017-2034. PubMed ID: 37488217
[TBL] [Abstract][Full Text] [Related]
7. Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer.
Schmid G; Notaro S; Reimer D; Abdel-Azim S; Duggan-Peer M; Holly J; Fiegl H; Rössler J; Wiedemair A; Concin N; Altevogt P; Marth C; Zeimet AG
BMC Cancer; 2016 Feb; 16():102. PubMed ID: 26879132
[TBL] [Abstract][Full Text] [Related]
8. Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer.
Tanaka N; Toyooka S; Soh J; Kubo T; Yamamoto H; Maki Y; Muraoka T; Shien K; Furukawa M; Ueno T; Asano H; Tsukuda K; Aoe K; Miyoshi S
Lung Cancer; 2012 Apr; 76(1):32-8. PubMed ID: 22047961
[TBL] [Abstract][Full Text] [Related]
9. The Methylation of the p53 Targets the Genes
Voropaeva EN; Pospelova TI; Orlov YL; Churkina MI; Berezina OV; Gurazheva AA; Ageeva TA; Seregina OB; Maksimov VN
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011313
[TBL] [Abstract][Full Text] [Related]
10. Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer.
Xie K; Liu J; Chen J; Dong J; Ma H; Liu Y; Hu Z
Gene; 2014 Jun; 543(1):101-7. PubMed ID: 24704024
[TBL] [Abstract][Full Text] [Related]
11. The association between miR-34 dysregulation and distant metastases formation in lung adenocarcinoma.
Daugaard I; Knudsen A; Kjeldsen TE; Hager H; Hansen LL
Exp Mol Pathol; 2017 Jun; 102(3):484-491. PubMed ID: 28512015
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal Cancer.
Shi X; Kaller M; Rokavec M; Kirchner T; Horst D; Hermeking H
Cell Mol Gastroenterol Hepatol; 2020; 10(2):391-418. PubMed ID: 32304779
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of miR-34a by aberrant CpG methylation in Kazakh patients with esophageal carcinoma.
Cui X; Zhao Z; Liu D; Guo T; Li S; Hu J; Liu C; Yang L; Cao Y; Jiang J; Liang W; Liu W; Li S; Wang L; Wang L; Gu W; Wu C; Chen Y; Li F
J Exp Clin Cancer Res; 2014 Feb; 33(1):20. PubMed ID: 24528540
[TBL] [Abstract][Full Text] [Related]
14. Detection of miR-34a promoter methylation in combination with elevated expression of c-Met and β-catenin predicts distant metastasis of colon cancer.
Siemens H; Neumann J; Jackstadt R; Mansmann U; Horst D; Kirchner T; Hermeking H
Clin Cancer Res; 2013 Feb; 19(3):710-20. PubMed ID: 23243217
[TBL] [Abstract][Full Text] [Related]
15. The miR-34 family in cancer and apoptosis.
Hermeking H
Cell Death Differ; 2010 Feb; 17(2):193-9. PubMed ID: 19461653
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.
Wang LQ; Kwong YL; Wong KF; Kho CS; Jin DY; Tse E; Rosèn A; Chim CS
J Transl Med; 2014 Feb; 12():52. PubMed ID: 24559316
[TBL] [Abstract][Full Text] [Related]
17. Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms.
Chim CS; Wan TS; Wong KY; Fung TK; Drexler HG; Wong KF
J Transl Med; 2011 Nov; 9():197. PubMed ID: 22082000
[TBL] [Abstract][Full Text] [Related]
18. Detection of miR-34a and miR-34b/c in stool sample as potential screening biomarkers for noninvasive diagnosis of colorectal cancer.
Wu XD; Song YC; Cao PL; Zhang H; Guo Q; Yan R; Diao DM; Cheng Y; Dang CX
Med Oncol; 2014 Apr; 31(4):894. PubMed ID: 24573638
[TBL] [Abstract][Full Text] [Related]
19. CpG island methylation status of miRNAs in esophageal squamous cell carcinoma.
Chen X; Hu H; Guan X; Xiong G; Wang Y; Wang K; Li J; Xu X; Yang K; Bai Y
Int J Cancer; 2012 Apr; 130(7):1607-13. PubMed ID: 21547903
[TBL] [Abstract][Full Text] [Related]
20. Curcumin activates a ROS/KEAP1/NRF2/miR-34a/b/c cascade to suppress colorectal cancer metastasis.
Liu C; Rokavec M; Huang Z; Hermeking H
Cell Death Differ; 2023 Jul; 30(7):1771-1785. PubMed ID: 37210578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
